Correlation Between Eton Pharmaceuticals and Organon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eton Pharmaceuticals and Organon Co, you can compare the effects of market volatilities on Eton Pharmaceuticals and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Organon.

Diversification Opportunities for Eton Pharmaceuticals and Organon

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Eton and Organon is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Organon go up and down completely randomly.

Pair Corralation between Eton Pharmaceuticals and Organon

Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 1.75 times more return on investment than Organon. However, Eton Pharmaceuticals is 1.75 times more volatile than Organon Co. It trades about 0.09 of its potential returns per unit of risk. Organon Co is currently generating about -0.03 per unit of risk. If you would invest  305.00  in Eton Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  906.00  from holding Eton Pharmaceuticals or generate 297.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eton Pharmaceuticals  vs.  Organon Co

 Performance 
       Timeline  
Eton Pharmaceuticals 

Risk-Adjusted Performance

26 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eton Pharmaceuticals are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Eton Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Organon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Organon Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of sluggish performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Eton Pharmaceuticals and Organon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eton Pharmaceuticals and Organon

The main advantage of trading using opposite Eton Pharmaceuticals and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.
The idea behind Eton Pharmaceuticals and Organon Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation